Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists.
Mediterranean journal of hematology and infectious diseases（2023）
关键词
Chronic ITP,ITP,New agents,New drugs,Refractory ITP,Thrombopoietin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要